Cancer Genetics tests in Dubai & UAE

Compare available Cancer Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

Listed price range

700.00–6,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Cancer Genetics test prices

Showing 46–59 of 59 matching tests.

Cancer Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-1151 ROS1 Gene Rearrangement (NSCLC) FISH Test This diagnostic test evaluates for the presence of ROS1 gene rearrangements in non-small cell lung cancer tissue samples using Fluorescence In Situ Hybridization (FISH). It identif...	Tissue (FFPE block or slide)	7–8 working days	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ROS1 gene rearrangement", "Chromosomal translocation involving ROS1"] Parameters [] Preparation [] Indications ["Diagnosis of non-small cell lung cancer (NSCLC)", "Guidance for targeted therapy selection in NSCLC"] Measurement technique Confirm with laboratory Codes LOINC: 94499-2 ICD-10: C34.90, Z12.2, Z15.09 Clinical summary This diagnostic test evaluates for the presence of ROS1 gene rearrangements in non-small cell lung cancer tissue samples using Fluorescence In Situ Hybridization (FISH). It identifies specific chromosomal translocations involving the ROS1 gene.
TEST-1932 SDHAF2 Gene (Hereditary Paraganglioma-Pheochromocytoma Type 5) Genetic Test This genetic test evaluates the SDHAF2 gene for mutations linked to hereditary paraganglioma-pheochromocytoma syndrome type 5.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SDHAF2 gene mutations", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number changes"] Parameters [] Preparation ["Mandatory genetic counselling and pedigree drawing before sample collection"] Indications ["Personal or family history of early-onset paraganglioma", "Multiple head/neck tumors", "Bilateral pheochromocytoma", "First-degree relatives of known SDHAF2 mutation carriers"] Measurement technique Confirm with laboratory Codes LOINC: 100218-4 ICD-10: Z15.09 Clinical summary This genetic test evaluates the SDHAF2 gene for mutations linked to hereditary paraganglioma-pheochromocytoma syndrome type 5.
TEST-2107 SDHD Gene Cowden Syndrome Type 3 Genetic Test This test evaluates the SDHD gene for pathogenic mutations associated with Cowden syndrome type 3, a hereditary cancer predisposition syndrome.	Whole Blood (Peripheral)	21–28 Days (3 to 4 Weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SDHD gene coding regions", "SDHD gene splice regions", "Pathogenic mutations"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed prior to testing"] Indications ["Individuals with a personal or family history suggestive of Cowden syndrome type 3", "Risk assessment for hereditary breast, thyroid, or endometrial cancer", "Cascade testing for family members of individuals with identified SDHD mutations"] Measurement technique Confirm with laboratory Codes LOINC: 65607-2 ICD-10: Q85.8 Clinical summary This test evaluates the SDHD gene for pathogenic mutations associated with Cowden syndrome type 3, a hereditary cancer predisposition syndrome.
TEST-1936 SDHD Gene Pheochromocytoma Type 1 Genetic Test This genetic test evaluates the SDHD gene for pathogenic variants associated with hereditary pheochromocytoma-paraganglioma syndrome.	Peripheral Whole Blood (EDTA) or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SDHD gene", "Single-nucleotide variants", "Indels", "Copy number changes"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your doctor.", "Inform your physician of all medications and supplements."] Indications ["Personal or family history of neuroendocrine tumors", "Suspicion of hereditary pheochromocytoma-paraganglioma syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21763-6 ICD-10: D35.0, Z13.8 Clinical summary This genetic test evaluates the SDHD gene for pathogenic variants associated with hereditary pheochromocytoma-paraganglioma syndrome.
TEST-1891 SRGAP1 Gene Mutation Analysis for Hereditary Nonmedullary Thyroid Cancer (Type 2) Test This genetic test identifies mutations in the SRGAP1 gene linked to hereditary nonmedullary thyroid cancer type 2.	Peripheral blood, extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SRGAP1 gene mutations", "Hereditary susceptibility to nonmedullary thyroid cancer type 2"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Individuals with a family history of nonmedullary thyroid cancer", "Personal history suggestive of hereditary cancer syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Z15.09 Clinical summary This genetic test identifies mutations in the SRGAP1 gene linked to hereditary nonmedullary thyroid cancer type 2.
TEST-1908 STAG1 Gene Prostate Cancer Genetic Test This test evaluates the STAG1 gene for variants associated with an increased risk of hereditary prostate cancer.	Peripheral Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["STAG1 gene variants", "Pathogenic and likely pathogenic mutations"] Parameters [] Preparation [] Indications ["Individuals with a strong family history of prostate cancer", "Men diagnosed with prostate cancer at a young age", "Families with multiple cancers suggesting hereditary syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 21620-6 ICD-10: Z80.43 Clinical summary This test evaluates the STAG1 gene for variants associated with an increased risk of hereditary prostate cancer.
TEST-1941 STK11 Gene (Peutz-Jeghers Syndrome) Genetic Test This genetic test evaluates the STK11 gene for mutations associated with Peutz-Jeghers syndrome, a hereditary condition increasing cancer risk.	Peripheral Whole Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["STK11 gene mutations (SNVs, indels, deletions, duplications)", "Germline genetic alterations"] Parameters [] Preparation ["Pre-test genetic counselling is mandatory", "No specific fasting required for blood sample"] Indications ["Diagnosis of Peutz-Jeghers syndrome", "Assessment of hereditary cancer risk", "Family screening for STK11 mutations"] Measurement technique Confirm with laboratory Codes LOINC: 85196-1 ICD-10: Q85.8 Clinical summary This genetic test evaluates the STK11 gene for mutations associated with Peutz-Jeghers syndrome, a hereditary condition increasing cancer risk.
TEST-2141 SUFU Gene Basal Cell Nevus Syndrome Genetic Test This test evaluates the SUFU gene for pathogenic variants associated with Nevoid Basal Cell Carcinoma Syndrome (Gorlin syndrome).	Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3 – 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the SUFU gene", "Full coding region and adjacent splice sites of the SUFU gene"] Parameters [] Preparation ["Mandatory pre-test genetic counselling", "Three-generation pedigree assessment"] Indications ["Diagnosis of Nevoid Basal Cell Carcinoma Syndrome (Gorlin syndrome)", "Family cascade screening for Gorlin syndrome", "Evidence-based surveillance for associated cancers"] Measurement technique Confirm with laboratory Codes LOINC: 90278-2 ICD-10: Q85.01 Clinical summary This test evaluates the SUFU gene for pathogenic variants associated with Nevoid Basal Cell Carcinoma Syndrome (Gorlin syndrome).
TEST-2029 SUFU Gene Sequencing for Familial Desmoplastic Medulloblastoma (NGS) Test This test analyzes the SUFU gene for germline pathogenic variants associated with familial desmoplastic medulloblastoma.	Whole Blood (EDTA tube), Extracted Genomic DNA (≥3 µg), or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["SUFU gene coding region", "Germline pathogenic variants"] Parameters [] Preparation [] Indications ["Individuals with personal or family history of medulloblastoma", "Asymptomatic relatives of affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Z15.09, C71.6 Clinical summary This test analyzes the SUFU gene for germline pathogenic variants associated with familial desmoplastic medulloblastoma.
TEST-2094 TGFBR2 Gene Colorectal Cancer, Hereditary Nonpolyposis Type 6 Genetic Test This test evaluates the entire TGFBR2 gene for germline mutations associated with an increased risk of hereditary colorectal cancer.	Whole blood (Peripheral)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in the TGFBR2 gene", "Pathogenic variants", "Likely pathogenic variants", "Variants of uncertain significance (VUS)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any anticoagulant therapy"] Indications ["Individuals with a personal or family history suggestive of Lynch syndrome", "Patients meeting specific clinical criteria for hereditary cancer risk assessment", "Pre-test genetic counselling completed"] Measurement technique Confirm with laboratory Codes LOINC: 48000-4 ICD-10: Z15.09 Clinical summary This test evaluates the entire TGFBR2 gene for germline mutations associated with an increased risk of hereditary colorectal cancer.
TEST-1310 TP53 Mutation Analysis (NGS) Test This test evaluates for mutations within the TP53 gene, a critical tumour suppressor gene.	Peripheral blood (EDTA whole blood) or bone marrow aspirate	15–18 business days	6,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline and somatic variants in the TP53 gene", "Single-nucleotide variants (SNVs)", "Small insertions and deletions", "Copy-number alterations"] Parameters [] Preparation ["No fasting or special preparation is required."] Indications ["Suspected Li-Fraumeni syndrome", "Hereditary cancer predisposition", "Somatic profiling of tumours"] Measurement technique Confirm with laboratory Codes LOINC: 21647-9 ICD-10: Z15.09 Clinical summary This test evaluates for mutations within the TP53 gene, a critical tumour suppressor gene.
TEST-3452 WT-1 Mutation Detection Test This test detects pathogenic variants in the WT1 gene associated with Wilms tumor and related syndromes.	Blood or bone marrow	18 working days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the WT1 gene"] Parameters [] Preparation ["No fasting required", "Ensure requisition form is fully completed"] Indications ["Diagnosis of Wilms tumor", "Diagnosis of Denys–Drash syndrome", "Diagnosis of Frasier syndrome", "Risk stratification for Wilms tumor"] Measurement technique Confirm with laboratory Codes LOINC: 92918-3 ICD-10: C64, Z15.07 Clinical summary This test detects pathogenic variants in the WT1 gene associated with Wilms tumor and related syndromes.
TEST-2117 XRCC3 Gene (Breast Cancer Susceptibility) Genetic Test This test evaluates the XRCC3 gene for pathogenic variants associated with an increased risk of hereditary breast cancer.	Whole blood EDTA	3 to 4 weeks from specimen receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["XRCC3 gene sequence", "Copy Number Variations (CNVs) in XRCC3"] Parameters [] Preparation ["Stay well hydrated", "Bring valid UAE national ID or Emirates ID", "Bring prior genetic test reports (if available)", "Bring detailed family history of cancer (if available)", "No fasting required"] Indications ["Family history of breast or ovarian cancer", "Personal history suggestive of hereditary cancer syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: Z15.01 Clinical summary This test evaluates the XRCC3 gene for pathogenic variants associated with an increased risk of hereditary breast cancer.
TEST-1915 ZNF783 Gene Prostate Cancer Genetic Test This test evaluates for mutations in the ZNF783 gene, which are associated with an increased risk of developing prostate cancer.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["ZNF783 gene mutations", "Inherited genetic variants"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of all medications"] Indications ["Prostate cancer risk assessment", "Prognostication", "Guiding precision therapy"] Measurement technique Confirm with laboratory Codes LOINC: 101262-9 ICD-10: Z13.85 Clinical summary This test evaluates for mutations in the ZNF783 gene, which are associated with an increased risk of developing prostate cancer.

Category overview

Cancer Genetics: overview

Empowering yourself with a deep understanding of your family’s oncological history is the most effective way to protect your future wellness. As a core pillar of our advanced Molecular Genetics department, comprehensive Cancer Genetics screening provides an in-depth evaluation of the complex hereditary pathways linked to various cancer syndromes. By leveraging cutting-edge genomic technology, this expansive screening delivers the critical clarity required to assess inherited risks, safely guiding customized oncology oversight, specialized prophylactic strategies, and informed family planning. Consistently ranked among the best diagnostic labs in Dubai and the UAE, DNA Labs ensures absolute patient confidentiality, uncompromising diagnostic precision, and prompt, reliable turnaround times. Prioritize your preventative health—book your cancer genetics testing in UAE, arrange a comfortable home sample collection, or consult our specialized genetic counselors.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.